ApprovalTrail

Drug · DIN 02280418

LANTUS

3ML CARTRIDGE OPTICLIK PRESENTATION

No: cancelled before it was sold

Authorized, then cancelled before it was ever sold in Canada.

Status Cancelled Pre Market since April 7, 2016.
Drug Identification Number (DIN)
02280418
Company (DIN owner)
Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
Schedule
Schedule d
Dosage form
Solution
Route
Subcutaneous
Therapeutic class (ATC)
Insulin glargine A10AE04
Class
Human
Record last updated
June 15, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
INSULIN GLARGINE100 UNITML

Other DINs named LANTUS